Much of the law governing corporate artificial intelligence rests on a single premise: that the protection from legal liability a company enjoys depends on the quality of the record it can produce. Directors defend oversight claims with minutes and charters. Issuers sustain the securities due-diligence defense with the documented trail of their investigation. Companies claim
My Life in Law – Naomi Goldsmith
In our latest My Life in Law blog, we speak to Naomi Goldsmith, who joined our employment team earlier this year as an Associate.
After graduating from University of Manchester with a law degree, Naomi trained in Manchester, completing a six-month secondment at Amazon, before relocating to London. Now, back in Manchester, she reflects on
Stock as Currency
In April 2026, SpaceX announced an agreement giving it the right to acquire the AI coding company Cursor for $60 billion in SpaceX stock after SpaceX went public. If that stock transaction did not occur, the agreement called for a $10 billion breakup fee, payable in cash. The stock was the point. What did the
AI-Related Securities Litigation Continues to Evolve
A securities class action filed against ZoomInfo Technologies, Inc. and certain of its directors and officers on June 25, 2026, highlights what may be the next phase of AI-related securities litigation. Unlike many earlier AI-related lawsuits, which alleged that companies overstated their AI capabilities, the Zoom complaint alleges that the company accurately described its AI
The D&O Diary Podcast Series – Episode 3: Securities Class Action Suit Filing Trends
The third episode of The D&O Diary Podcast Series is now live. Building on our June 30, 2026, post discussing first-half federal court securities class action lawsuits, this episode explores the factors and trends driving the number of current suit filings.
In this podcast, we discuss the overall increase in the total number of federal
New Lawsuit Suggests Evolution in Cross-Border Securities Fraud
For more than two decades, The D&O Diary has chronicled successive waves of securities litigation involving foreign companies with shares listed on U.S. exchanges. The Chinese reverse merger cases of the early 2010s centered on alleged accounting fraud. More recently, a new cluster of lawsuits has emerged involving low-float stocks, artificial intelligence announcements, SPACs, and
Managing Litigation Risk in AI and Crypto Colocation Agreements
To operate in the crypto or AI space, it is often necessary for parties to enter into a Hosting Services Agreement or Colocation Agreement to secure capacity in a data center. Those agreements can contain landmines that erupt in litigation, and unless they are quickly and satisfactorily resolved, they can threaten essential operations and cause
A Pathway for Clinical AI Developers Opens: FDA Clears First Software as a Medical Device With Patient-Facing LLM
On June 25, 2026, UpDoc Inc., a clinical AI company, announced that it received clearance from FDA for what the company describes as the first Software as a Medical Device (SaMD) that uses patient-facing large language models (LLMs). UpDoc describes its platform as an enterprise-ready agentic clinical AI platform designed to enable clinicians to deploy
Industry Survey: AI’s Impact on D&O Liability and Insurance
How will artificial intelligence (AI) impact the D&O liability and insurance landscape?
The D&O Diary, in collaboration with Allianz Commercial, has prepared a survey, to allow us to better understand the views of D&O insurance industry participants about AI. The survey form is available here. The survey will remain open through July 20,
New Microsoft Derivative Lawsuit: “Silent AI” and D&O Exposure
One of the much-discussed concerns in the insurance industry about artificial intelligence (AI) is the risk of “silent AI” – that is, the seepage of AI-related matters into various insurance coverages that were not intended (at least not consciously) to provide coverage for these kinds of exposures. A new shareholder derivative lawsuit filed against the